Barclays
ASPN icon

Barclays’s Aspen Aerogels ASPN Stock Holding History

Barclays’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-83,400
Closed -$236K – 5041
2025
Q4 		$236K Buy
+83,400
New +$430K ﹤0.01% 4228

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $1.04B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Barclays's ASPN Position: Q2 2026 in Review

Barclays reduced its Aspen Aerogels (ASPN) stake by 8.1% in Q2 2026, selling an estimated $7.32K and leaving 16,955 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #4010.

Barclays first reported a position in ASPN in Q2 2014 and has held it in 35 quarters since. The position peaked at $11.9M in Q2 2014. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Barclays held 16,955 shares of Aspen Aerogels worth $107K as of Q2 2026.
  • Barclays sold 1,492 Aspen Aerogels shares in Q2 2026, an estimated $7.32K.
  • Aspen Aerogels made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4010 holding.
  • Barclays first reported a position in Aspen Aerogels in Q2 2014 and has held it in 35 quarters since.
  • Barclays's Aspen Aerogels position peaked at $11.9M in Q2 2014.
  • 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.